Rare and Neglected Diseases Archives - Australian Biotech Company News

Home Tags Rare and Neglected Diseases

Biotechnology

Current and Future CEOs See Opportunities in Editas’ Challenges

BioChannel - April 26, 2022

Biotechnology

StockWatch: Kaleido Shares Crater as Company Ceases Operations

BioChannel - April 8, 2022

Biotechnology

Same Drug, New Partner: Capricor in Up-to-$735M Deal for DMD Cell...

BioChannel - February 1, 2022

Biotechnology

NeuBase Sets a Course for the Clinic

BioChannel - April 10, 2020

Biotechnology

Trial Triumphs, Takeover Talk Boost Reata Pharmaceuticals

BioChannel - February 10, 2020

Biotechnology

Gene Therapy Developer Passage Bio Files for $125M IPO

BioChannel - February 3, 2020

Biotechnology

AGTC Plans Pivotal Trial for XLRP Gene Therapy

BioChannel - January 9, 2020

Biotechnology

AGTC Grows Preclinical Pipeline with Gene Therapies for Congenital Hearing Loss,...

BioChannel - November 25, 2019

Biotechnology

Dicerna, Novo Nordisk Eye 30+ Liver Targets in Up-to-$3.8B RNAi Partnership

BioChannel - November 21, 2019

Biotechnology

Alexion to Acquire Achillion for $930M+, Expanding Rare Disease Portfolio

BioChannel - October 16, 2019

12 Page 1 of 2

Stay connected

Recent posts

Study provides long-term look at ways to control wildfire in sagebrush steppe ecosystem

BioChannel - May 16, 2022

Psychotropic Compound Synthesized from Rainforest Tree

BioChannel - May 16, 2022

CRISPR Can Help The Switch To Sustainable Cosmetics

BioChannel - May 16, 2022

Random article

Study provides long-term look at ways to control wildfire in sagebrush...

Psychotropic Compound Synthesized from Rainforest Tree

CRISPR Can Help The Switch To Sustainable Cosmetics

Vir Biotechnology (VIR) Stock: $125 Price Target And Buy Rating –...